Faculty

Pilar Agudo Quílez (MD, PhD). Responsable de la Unidad de Cardio-oncología del Hospital Universitario Ramón y Cajal, Madrid. Cardióloga clínica con formación y experiencia de más de 10 años en el campo de la cardio-oncología. Certificación acreditada por la Sociedad Internacional de Cardio-Oncología (ICOS). Participación activa en investigación clínica y autoría de publicaciones en revistas científicas nacionales e internacionales. Comprometida con la docencia y formación de estudiantes y residentes. Miembro del Grupo de Trabajo de Cardio-Oncología de la Sociedad Española de Cardiología, del Consejo de Cardio-Oncología de la Sociedad Europea de Cardiología (ESC) y del capítulo español de ICOS.

More information soon.

Specialist in Internal Medicine at the Systemic Autoimmune Diseases Unit (CSUR), Hospital Universitario La Paz, Madrid, and a researcher affiliated with Universidad Autónoma de Madrid and IdiPAZ. Holds a Cum Laude PhD on cardiac involvement and pulmonary hypertension in systemic lupus erythematosus. His research focuses on cardiac manifestations of systemic autoimmune diseases and inflammatory myopathies, including a recent study establishing troponin-based diagnostic thresholds for cardiac involvement in myositis. He also studies interstitial lung disease in connective tissue diseases and Sjögren's syndrome, with a strong interest in applying artificial intelligence to clinical research.

Pietro Ameri is Associate Professor of Cardiovascular Diseases and Coordinator of the PhD Program in Translational and Clinica Internal Medicine at the University of Genova, Italy. He also leads the Translational Cardiovascular Unit and the cardio-oncology service at the affiliated hospital IRCCS Ospedale Policlinico San Martino. He is currently Secretary of the ESC Council of Cardio-oncology and has served as chairperson of the first ESC Cardio-Oncology Conference.
His primary interests are cardio-oncology and heart failure, including pulmonary hypertension.
Pietro Ameri's research group includes biologists, biotechnologists and physicians and is funded by several grants.
If he was asked where he would like to go again, now he would answer Dunmore Head, any trail in Liguria with a view of the sea, or the Hudson River Park

More information soon.

Chiara BUCCIARELLI-DUCCI, MD, PhD, FESC, FRCP, FSCMR, FACC, FEACVI

Dr Bucciarelli-Ducci is a consultant cardiologist and imaging specialist at the Royal Brompton and Harefield Hospitals, Guys’ and St Thomas NHS Trust in London, United Kingdom. She is also an honorary Reader (Associate Professor) at the School of Biomedical Engineer and Imaging Sciences, Faculty of Medicine and Life Sciences at King’s College London. From 2010 to 2021 she developed and led with colleagues the CMR Unit of the Bristol Heart Institute at the University Hospitals Bristol NHS Trust and a senior lecturer in cardiology and cardiac imaging at the University of Bristol. In 2012 she was awarded a PhD in CMR at the National Heart and Lung Institute (NHLI), Imperial College London. She has collected over 10 international awards, the latest being Imperial College Alumni Emerging leaders award in 2022.

Since 2019 she is also the Chief Executive Officer of the Society for Cardiovascular Magnetic Resonance (SCMR) with headquarters in the United States. She is currently completing an MSc in Health Economics at the London School of Economics.

She is the past European Association of Cardiovascular Imaging (EACVI) Vice-President and chair of the cardiac MRI section (2016-2018), within the European Society of Cardiology (ESC) and past Secretary of the EACVI (2018-2019). Since September 2020, she is the Deputy Editor (Imaging) of the European Heart Journal. She is in the editorial board of JACC Cardiovascular Imaging, Circulation Cardiovascular Imaging and European Heart Journal Cardiovascular Imaging. She is an enthusiast advocate on the use of cardiovascular imaging to improve patients’ diagnostics, management and thus prognosis.

Virginia Calvo de Juan, MD, PhD. Licenciada en Medicina, Universidad Autónoma de Madrid (UAM), 19/07/2005. Realizó la residencia de Oncología Médica en el H.U. de La Princesa, Madrid, 2006-2010. Ha trabajado como FEA de Oncología Médica en diversos hospitales, H.U. Ramón y Cajal (2010-2011), H.U. Severo Ochoa (2011-2012) y actualmente desde abril de 2012 en el H.U. Puerta de Hierro-Majadahonda, Madrid. Doctora en Medicina por la UAM (29/05/2017). Máster en Medicina Paliativa y Tratamiento de soporte de los pacientes con cáncer, UAM (2008-2009). Título Propio de Inmuno-Oncología, Universidad de Navarra (2016). Título Experto en Investigación Clínica, Universidad Internacional Menéndez Pelayo (2017-2018). Título Propio Diagnóstico y Tratamiento de pacientes con carcinoma de pulmón, UAM (2019). Título Experto en Oncología de Precisión, Universidad Francisco de Vitoria (2021-2022). Curso Experto en Cáncer de Pulmón, Universidad Francisco de Vitoria (2024). Profesora asociada de la UAM desde enero de 2019. Autora de numerosas comunicaciones a congresos nacionales e internacionales y capítulos de libro, así como de 90 publicaciones en revistas nacionales e internacionales. Investigadora principal y subinvestigadora de ensayos clínicos fase I-IV, en el H.U. Puerta de Hierro Majadahonda, Madrid, desde 2012. Investigadora colaboradora de diversos proyectos de investigación nacionales e internacionales e investigadora principal del proyecto nacional PI22/01603.

Miguel A. Canales, MD, PhD is Consultant in Hematology at Clínica Universidad de Navarra (Pamplona, Spain) and Professor of Medicine at Universidad de Navarra. He earned his MD and PhD from Universidad Autónoma de Madrid, trained in Hematology at Hospital Universitario La Paz, and completed a fellowship in Lymphoma and Myeloma at MD Anderson Cancer Center, Houston. Former Section Head and Director of the Hematopoietic Transplant Program at La Paz. He has authored more than 100 peer-reviewed publications, and led numerous clinical trials. At Clínica Universidad de Navarra, his clinical and research activity is dedicated to lymphomas and lymphoproliferative disorders.

Dr. Daniela Cardinale graduated from the University of Milan(1987) and specialized in Cardiology (1992). She holds a PhD in Cardiovascular Physiopathology (2009). She is Director of the Cardioncology Unit of the European Institute of Oncology, Milan, where she has been working since 1994. She has previously worked at the Operative Unit of Intensive Cardiac Care of the Centro Cardiologico Monzino (1987-1990) and at the Cardiology Division of S. Raffaele Hospital of Milan (1990-1994). Her professional experience and investigational interests focus on prevention, early detection, monitoring and treatment of cardiotoxicity; screening of cardiotoxicity in patients with cardiac disease. She is fellow of the European Society of Cardiology.

More information soon.

Medicina Familiar y Comunitaria. Centro de Salud Milladoiro. Área Sanitaria de Santiago de Compostela. Miembro de los GGTT de Hipertensión Arterial y Enfermedad Cardiovascular y Diabetes, Endocrinología y Metabolismo de SEMERGEN. Vocal Junta Directiva Nacional SEMERGEN. Responsable de la Agencia de Investigación de SEMERGEN.

Graduada en Medicina por la Universidad de Autónoma de Madrid. Beca de Excelencia por la Comunidad Autónoma de Madrid. Especialista en Cardiología por el Hospital Universitario de La Paz. Observership en Insuficiencia Cardiaca Avanzada y Trasplante del Montefiore Hospital de Nueva York. Beca Dr. José María Maroto de la Sociedad Española de Cardiología para especialización en Rehabilitación Cardiaca. Médico Adjunto de Cardiología de la Unidad de Rehabilitación Cardíaca. Máster Universitario en Diagnóstico por Imagen Cardiaca (Universidad Católica de Murcia). Profesora máster en insuficiencia cardiaca; Campus IMAS. Clínica colaboradora docente del grado en Medicina de la Universidad Autónoma de Madrid.

Doctor en medicina por la Universidad Autónoma de Madrid. Médico especialista en hematología y hemoterapia. Miembro de la junta directiva de la Sociedad Española de Hematología y Hemoterapia. Enlace de la Asociación Europea de Hematología con el Council de Cardio Oncología de la Sociedad Europea de Cardiología.

More information soon.

Jefe de Sección de Oncología Médica del Hospital Universitario La Paz en Madrid. Director Científico e impulsor de la Unidad de Innovación del Instituto de Investigación IdiPAZ. Profesor Asociado de Oncología en la Universidad Autónoma de Madrid y codirector del Aula Cáncer e Innovación. Su interés asistencial y científico se centra en la biología molecular del cáncer de pulmón y tumores torácicos, así como en factores predictivos de respuesta y etiopatogénicos. Autor de más de 200 artículos internacionales, es miembro de ASCO, IASLC y ESMO. Actualmente ocupa la vicepresidencia de la Sociedad Española de Oncología Médica (SEOM).

Médico Adjunto desde hace 21 años en el Servicio de Hematología y Hemoterapia del Hospital Universitario La Paz, responsable en la actualidad del Hospital de Día de Hematología y de la Unidad de Ensayos Clínicos del Servicio y consulta monográfica de Síndromes Mielodisplásicos y Leucemia Mieloide Crónica. Además es autora de las actuales Guías Españolas de SMD y LMMC del GESMD edición 2020 y Manual de Recomendaciones en Leucemia Mieloide Cronica del Grupo Español de Leucemia Mieloide Cronica de (GELMC) edición 2024 y de 88 publicaciones en revistas nacionales e internacionales.

More information soon.

Victoria Delgado, MD, PhD, FESC

Dr. Victoria Delgado, is currently the head of the cardiovascular imaging department of the Heart Institute at the University Hospital Germans Trias i Pujol in Badalona, Spain. She graduated in medical school at the University of Barcelona (Spain), accomplished her PhD at the Leiden University.
She is currently president of European Association of Cardiovascular Imaging of the European Society of Cardiology. She is also president of the Scientific Commission Sciences de la Vie et de la Santé - 4 (SVS-4) of the F.R.S.-FNRS (Belgium) and has formed part of several grant selection panels. She is currently Senior Editor of Circulation.

Santo Dellegrottaglie, MD, PhD, is Director of the Advanced Cardiovascular Imaging Unit at Clinica Villa dei Fiori Acerra (Naples, Italy). He completed advanced training in cardiovascular magnetic resonance (CMR) at Mount Sinai Medical Center (NY, USA) and Niguarda-Cà Granda Hospital (Milan, Italy) and is the immediate past-Chairman of the CMR Working Group of the Italian Society of Cardiology. His clinical and research interests focus on CMR, cardiomyopathies, myocarditis, heart failure, pulmonary hypertension and multimodality imaging. He has authored over 150 peer-reviewed publications and served as co-editor for the textbook “Case-based Atlas of Cardiovascular Magnetic Resonance” (2023) Springer ed.

More information soon.More information soon.

Licenciada en medicina y cirugía por la Universidad de Valladolid (2013). Especialista en cardiología por la Clínica Universidad de Navarra (2018). Doctorado por la universidad de Navarra ( 2020) Profesora asociada de la Universidad de Salamanca. Máster de cardio RM por la Universidad Francisco de Vitoria (2019). Formación en TC cardiaco en Lenox Hill hospital, New York (2010 y 2012) y Hackensack Hospital, New Jersey (2018). Acreditada nivel 3 de TC y RMC por la EACVI y de ecocardiograma transtorácico.

More information soon.

Dimitrios Farmakis, MD, PhD, FESC, FHFA, is an Ass. Professor of Cardiology and head of the Cardio-Oncology Clinic and the Cardiac Clinic for Haemoglobinopathies at Athens University Hospital “Attikon”, National and Kapodistrian University of Athens (NKUA) Medical School, Greece and an academic advisor to Thalassaemia International Federation (TIF).

He has a long teaching experience at under- and/or post-graduate level at the NKUA, the European University Cyprus, the University of Cyprus and the University of Zurich. He has further been invited as a speaker or chair to more than 350 congresses.

His research spans heart failure, cardio-oncology and hemoglobinopathy-associated heart disease. He has published more than 350 articles, 320 of which in highly rated PubMed journals with more than 43,000 citations and an h index of 75, while he participated with more than 225 abstracts in congresses. He has authored 72 chapters in medical textbooks and 5 complete medical textbooks. He has served as principal investigator and member of executive and steering committees in national and international trials and research projects.

He sits on national and international scientific committees, guideline taskforces and expert panels. He is member of the Board and Liaison Officer of the ESC Cardio-Oncology Council and Chairperson-Elect of the ESC Cardio-Oncology Council Certification Committee.

He has received awards from international organizations, such as Harvard Medical School, American Heart Association, European Hematology Association, United Arab Emirates Government, Thalassaemia International Federation and others.

Specialist in Angiology and Vascular Surgery at Hospital Viamed Montecanal in Zaragoza. A Cum Laude PhD and expert in endovenous laser ablation, she stands out for her international presence within the World International Union of Phlebology and for her role as Newsletter Officer on the Board of Directors of the Pan-American Society of Phlebology and Lymphology.

She combines her clinical practice with teaching in the Master’s Degree in Clinical Phlebology and Management of Aesthetic Alterations of the Lower Limb at the European University of Madrid, and with institutional leadership as Secretary of the Spanish Chapter of Phlebology and Lymphology. She is a frequent speaker at international scientific forums.

José Javier Fuster, PhD is Associate Professor and Group Leader at the Spanish National Center for Cardiovascular Research (CNIC) in Madrid (Spain), where he is also the Coordinator of the Scientific Program on Novel Mechanisms of Atherosclerosis. His research group at CNIC investigates the interplay between the hematopoietic and the cardiovascular systems in the context of cardiovascular disease, with a particular focus on the pathophysiology of atherosclerosis and heart failure. He is internationally recognized for his pioneering work on age-related clonal hematopoiesis and its impact on cardiovascular disease.

Maria Rosaria Galdiero is an Associate Professor of Internal Medicine at the Department of Tanslational Medical Sciences (DisMeT), University of Naples Federico II, Naples (Italy).
She had her Master’s Degree in Medicine and Surgery summa cum laude in 2007, and Residency in Allergy and Clinical Immunology in 2012. Then she moved to Milan, where she had her PhD at the Humanitas Clinical and Research Center in 2015. She then come back to Naples and after a post-doctoral fellowship, she become Assistant Professor of Internal Medicine in 2016.
Prof. Galdiero research activity was focused on the molecular and cellular mechanisms of innate immunity and inflammation in health and disease, with particular reference to the role played by phagocytes in cancer and to the mechanisms underlying the bidirectional cross-talk between human phagocytes and neoplastic cells.

Valentín García-Gutiérrez obtained his medical degree from the University of Granada in 2003. He completed his residency in Hematology and Hemotherapy at Hospital Universitario Ramón y Cajal in Madrid, where he also earned his PhD and served as a clinical hematologist on the bone marrow transplant ward. During his tenure, he led programs focused on myeloproliferative disorders. In 2016, he was appointed Associate Professor of Medicine at the University of Alcalá, Spain.

Dr. García-Gutiérrez has collaborated with prestigious international institutions, including the University of Texas MD Anderson Cancer Center (Leukemia Department and Bone Marrow Transplantation Program), the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (Leukemia Department) in Mexico City, and Memorial Sloan Kettering Cancer Center (Bone Marrow Transplantation Center) in the United States.

He has been the principal investigator for over 45 clinical trials (phases II–IV) focused on chronic myeloproliferative disorders and bone marrow transplantation. Additionally, he coordinates six national clinical trials on chronic myeloid leukemia. His extensive research has resulted in over 150 international publications, contributions to eight national guidelines, and authorship of ten book chapters. He is a frequent speaker at national and international hematology congresses.

Currently, Dr. García-Gutiérrez serves as President of the Spanish Chronic Myeloid Leukemia Group (GELMC) and Vice President of the Spanish Society of Hematology and Hemotherapy. He was recently appointed as Head of Area 3 (Cancer) at the Ramón y Cajal Health Research Institute (IRYCIS). His work has secured significant public and private funding, notably through projects such as PI21 and PI24 in 2021.

Dr. García-Gutiérrez’s research focuses on the prognostic characterization of hematological malignancies, treatment responses, and the immune characterization of oncohematological patients undergoing diverse therapeutic approaches, including the immune response to infections.

Dr. Inés García-Lunar (MD, PhD, FESC) is a cardiologist specialized in non-invasive cardiovascular imaging and a group leader at the National Center for Cardiovascular Research (CNIC) in Madrid, where she also serves as clinical co-leader of the scientific program on New Mechanisms of Atherosclerosis. After completing her training in Medicine and Cardiology in Madrid, she specialized in advanced cardiovascular imaging at Mount Sinai Hospital in New York. She has over 10 years of experience in clinical cardiology, cardiovascular imaging, and translational research as well as in population-based cardiovascular cohorts at the CNIC. Her research focuses on the early identification and prevention of cardiovascular disease through the use of non-invasive imaging modalities.

More information soon.

Dr José-Ángel Hernández-Rivas is Head of the Hematology Service at the Infanta Leonor University Hospital in Madrid, Spain. He is also Associate Professor of the Department of Medicine of the Complutense University of Madrid. He belongs to the main Scientific Societies related to the specialty and collaborates in various cooperative scientific groups at a national and European level.

He completed his training as a resident intern at the Germans Trias i Pujol University Hospital in Badalona (Barcelona) and has a Master's Degree in Health Management and Management from the Collegiate Medical Organization, a Master's Degree in University Education from the European University of Madrid and a Master's Degree in Hematopoietic Transplantation from the University of Valencia, Spain. In addition, he has completed the Postgraduate Diploma in Clinical Management for Hematologists at the Pompeu i Fabra University of Barcelona and the IESE Health Management and Executive Development Program.

Since 2008 he has been a Doctor of Medicine with an extraordinary award thesis, with a study on prognostic factors from the biological point of view in CLL. It is in this field where he has carried out his main research career.

He is the author of 233 publications in books and biomedical journals, including the New England Journal of Medicine, Journal of Clinical Oncology, Blood, Journal of Hematology and Oncology, Lancet Haematology, Hemasphere, Leukemia or Haematologica, among others, and 490 communications in Hematology meetings.

Dr. Hernández Rivas is the principal investigator in more than a hundred clinical trials, a reviewer of articles in 30 peer-reviewed journals, has directed doctoral theses and end-of-degree projects in Medicine and the end of a Master's degree, belongs to the Agency's Network of Experts Spanish Medicine and Health Products, is a Reviewer of the Health Research Fund of Spain and has accreditation by ANECA for Full Professor of Medicine.

Licenciado en Medicina y Cirugía por la Universidad Complutense de Madrid en 2008.
Especialidad de Oncología Médica en el Hospital Universitario de la Paz en el periodo de 2009 a 2014. Desde entonces, forma parte del Servicio Oncología médica, perteneciendo a la Unidad de Cáncer Heredofamiliar y de la Unidad de Neoplasias torácicas en ese mismo hospital.
Como parte de su formación, ha realizado varios másteres y títulos de experto y ha sido ponente y autor de publicaciones nacionales e internacionales relacionadas con neoplasias torácicas. Actualmente forma parte del grupo de “Terapias experimentales y Biomarcadores en Cáncer” del Instituto de Investigación de la Paz (IDIPAZ).

Borja Ibáñez, nacido en Madrid en 1975, es médico por la Universidad Complutense de Madrid y doctor por la Autónoma de Madrid. Cardiólogo formado en la Fundación Jiménez Díaz, recibió formación en investigación en el Mount Sinaí Medical Center de Nueva York entre los años 2005 y 2008.

Desde su regreso a España, el Dr. Ibáñez compagina su actividad investigadora en el Centro Nacional e Investigaciones Cardiovasculares (CNIC), donde es actualmente director Científico del Centro (siendo el director general el Dr Valentín Fuster) y además director del Departamento de Investigación Clínica, con la actividad clínica, atendiendo pacientes como cardiólogo intervencionista en el Hospital Universitario Fundación Jiménez Díaz. Su actividad clínica y científica se ha centrado en el estudio de las enfermedades del músculo cardiaco (miocardio), haciendo contribuciones relevantes en el campo del infarto agudo de miocardio y en el de la protección cardiaca en pacientes con cáncer que reciben tratamientos con potencial dañino sobre el sistema cardiovascular.

Dirige estudios multinacionales financiados por la Comisión Europea, incluyendo la realización de ensayos clínicos y ha publicado más de 400 artículos científicos en las revistas más prestigiosas a nivel mundial, siendo uno de los autores más referenciados en Europa. Ha recibido financiación competitiva de agencias nacionales e internacionales de forma ininterrumpida desde 2010. Ha sido elegido por la Sociedad Europea de Cardiología como el responsable de coordinar las guías de práctica clínica para el tratamiento de pacientes con infarto agudo de miocardio en dos ocasiones (2017 y 2023), siendo el “Chairman” más joven de la historia de la Sociedad Europea de Cardiología, y el único que ha repetido en esta tarea.

Es inventor de múltiples patentes, relacionadas con tratamiento para enfermedades cardiovasculares y de desarrollo de nuevas secuencias de resonancia magnética para adquisición acelerada (transformando un estudio de resonancia magnética estándar de 60 minutos en tan sólo 40 segundos).

Ha recibido múltiples premios de investigación, destacando el Premio Princesa Girona en 2010, premio fundación Banco Sabadell en 2017, premio constantes y vitales en 2020, premio Fundación Occident en 2021. Galardonado con orden del mérito “Cruz Azul Zendal-Balmis” por su lucha contra la pandemia COVID19. Aparece en la lista anual FORBES de los mejores médicos de España ininterrumpidamente desde 2019 hasta la actualidad.

Es muy activo en la formación de jóvenes cardiólogos e investigadores, habiendo dirigido 34 tesis doctorales hasta la fecha.

Dolores Isla, MD PhD, is currently a Consultant in Medical Oncology since 1993, Head of the Medical Oncology Department and the Thoracic Cancer Unit as well, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. She is President of ICAPEM (Association for Research on Lung Cancer in Women).

She is the principal investigator of many different research trials based on lung cancer, preferently on new drugs, translational research, immunotherapies and personalized therapies. (https://orcid.org/0000- 0002-2483-198X).

Medical degree from the University of Oviedo. Completed residency training (MIR) and is currently a staff medical oncologist at Hospital Universitario La Paz (Madrid). Clinical and research work currently focuses on Thoracic Oncology. Member of the Lung Tumor Board and the Cardio-Oncology Committee. Experience in managing hospitalized patients and in the care of gynecologic and urologic cancers.

Médico de Famila, CS Universitario Dr. Castroviejo, Madrid. Responsable de la comisión de RCV.
Master Universitario en Riesgo Cardiovascular. Universidad de Vitoria-Gasteiz.
Certificate of Excellence in Lipidology. European Atherosclerosis Society.
Tutor de Residentes. Unidad Docente Norte. Hospital Universitario La Paz. (Madrid).
Colaborador clínico docente. Departamento de Medicina, Facultad de Medicina, Universidad Autónoma de Madrid.
Miembro del claustro de profesores. Grupo de Enfermedad Cardiovascular. LIVEMED IBERIA.
GdT de Enfermedad Cardiovascular. SEMERGEN.
Miembro numerario SEA ( Sociedad Española Arterioesclerosis). GdT AP y Dislipemia Aterogénica.

More information soon.

Estefanía Linares Espinós, MD PhD FEBU

Uróloga del Hospital La Paz, está especializada en el manejo global del cáncer de próstata. Licenciada en Medicina (2008) y Doctorada en Medicina y Cirugía (2016) por la Universidad Autónoma de Madrid, completó su formación en urología con Fellowship en Cirugía Robótica y Laparoscopia Avanzada, Institut Montsouris – Paris (2015). Trabaja a su vez en el Instituto Lyx Urología, especializados en el diagnóstico y tratamiento del cáncer de próstata. Fellow del European Board of Urology (2014), es en la actualidad asociada de las Guías de Cáncer de Próstata de la Asociación Europea de Urología.

Próximamente

Dr. Rebeca Lorca is a cardiologist and head of the Familial Heart Disease Unit at the University Central Hospital of Asturias (HUCA), a nationally accredited reference center (CSUR) in Spain. She also leads the Cardio-Oncology Unit at HUCA and serves as an Associate Professor of Medicine at the University of Oviedo. She specializes in cardio-oncology and inherited cardiovascular conditions, with a focus on cardiomyopathies, channelopathies, and genetic risk assessment. She is accredited in Human Genetics by the Spanish Association of Human Genetics (AEGH).

More information soon.More information soon.

Dr. Pilar Martín leads the Cardio-Immunology group at the National Center for Cardiovascular Research (CNIC, Madrid, Spain). Her research has contributed to establishing the role of T cells and microRNAs in the pathophysiology of inflammatory cardiomyopathies. Dr. Martín joined the Council of Cardio-Oncology Immunotherapy Study Group of the European Society of Cardiology (ESC) as Secretary in 2024 and is an Associate Editor of JACC: CardioOncology. Recently, she was appointed Group Leader at the Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), coordinating basic and clinical research groups at Hospital Universitario de la Princesa and CNIC, fostering collaborative translational cardiovascular research.

Ana Martín García, MD, PhD, es cardióloga adjunta en el Servicio de Cardiología y coordinadora del programa de Cardio-Oncología del Complejo Asistencial Universitario de Salamanca. Es investigadora clínica del grupo cardiovascular del Instituto de Investigación Biomédica de Salamanca (IBSAL) y del CIBER-CV, además de profesora asociada en el Departamento de Medicina de la Universidad de Salamanca. También es miembro de la Junta Directiva del grupo de trabajo de Cardio-Oncología de la Sociedad Española de Cardiología y miembro certificado del capítulo español de la International Cardio-Oncology Society.

More information soon.

Coordinadora de imagen cardiaca del servicio de Cardiología del Hospital Clínico Universitario de Santiago de Compostela con especial dedicación a la ecocardiografía e imagen multimodal. Doctora en Medicina por la Universidad de Navarra. Especialista en Cardiología. Past president de la Asociación de Imagen Cardiaca de la Sociedad española de Cardiología. Miembro del Grupo de trabajo de cardio-oncología de la SEC. Miembro del Council de cardio-oncología de la ESC. Su foco de investigación está en cardiooncología y en imagen cardiaca en valvulopatías. Pertenece al grupo CIBER-CV.

Doctora en Medicina, especialista en Cardiología.
Jefa de Sección del Cardiología del Hospital Clínico Universitario de Santiago de Compostela.
Directora del Master Universitario de Avances en Cardiología SEC-UCAM.
Profesora del Master en Cardio-Onco-Hematología SEIC-UFV.
Miembro del Grupo de Cardio-Oncologia SEC y del Council Cardio-Oncology ESC.

Dolores Mesa Rubio is a cardiologist specializing in cardiac imaging. She earned her Medical Degree (Cádiz, 1986), specialist qualification in Cardiology, and Doctorate from the University of Córdoba (1997), plus three master's degrees (imaging, clinical management, and research methodology). She has headed the Cardiac Imaging Unit at Reina Sofía University Hospital (Córdoba) since 2018, served as President of the Andalusian Society of Cardiology (2021–2024), and has chaired its Foundation since 2024. She has supervised 7 doctoral theses (all cum laude), participated in more tan 20 research projects, and sits on several editorial boards. Scientific output: moro tan 200 articles, 24 book chapters, about 1000 abstracts, H-index 24.

Médico Especialista en Cardiología empleada en el Hospital Universitario Puerta de Hierro Majadahonda, Madrid desde 2015. Subespecialidades: Insuficiencia cardiaca avanzada y Cardio-Oncología.

Doctor en Medicina por la Universidad Autónoma de Madrid en 2017.

Coordinadora de la Unidad de Cardio-Oncología del Hospital Puerta de Hierro Majadahonda Madrid desde 2016.

Miembro del grupo de trabajo de Cardio-Oncología de la Sociedad Española de Cardiología.

Miembro del Spanish Chapter de la International Cardio-Oncology Society del Council de Cardio-oncología de la European Society of Cardiology.

Acreditación en Cardio-Oncología por la International Cardio-Oncology Society en Nov 2020.

Pedro Moliner MD, PhD. Cardiólogo, coordinador de la Unidad de Cardio-Oncología del Hospital de Bellvitge con el Instituto Catalán de Oncología. Investigador postdoctoral del grupo de enfermedades cardiovasculares BioHeart del Instituto de Investigación Biomédica de Bellvitge (IDIBELL) y miembro del grupo de investigación en red CIBER-CV, h-index:30. Coordinador del Grupo de Cardio-Oncología de la Societat Catalana de Cardiología (2021-2024), actualmente miembro de la junta directiva del Grupo de Cardio-Oncología de la Sociedad Española de Cardiología (SEC). Miembro del Cardio-Oncology Committee de la Heart Failure Association. Fellow of the International Society of Cardio-Oncology (FICOS) y Social Media Consultant de la revista JACC Cardio-Oncology.

Especialista en Medicina Familiar y Comunitaria. Profesor Titular de Medicina, Universitat Jaume I, Castellón. Especialista Universitario en Gestión de la Cronicidad. Clinical Hypertension Specialists por la European Society of Hypertension.

ORCID: https://orcid.org/0000-0002-2985-6078. Investigador en 8 proyectos FISS. Vocal Junta Directiva Nacional de SEMERGEN. Responsable del área de formación (2024-…). Miembro del Consejo Asesor de la Revista Medicina de Familia, Semergen. Editor Frontiers Cardiovascular Medicine. Miembro CEICm de Atención Primaria de la Comunidad Valenciana. Miembro del Comité Español Interdisciplinar de Prevención Vascular (CEIPV-ICIII). Académico correspondiente de la Real Academia de Medicina de la Comunidad Valenciana.

Chief of Section, Hematology department.
Hematology and Hemotherapy Specialist responsible for the Haemostasis and Thrombosis Unit (laboratory and clinic) and Eritropathology of the Hematology and Hemotherapy Service, Gregorio Marañon University Hospital.
Associate Profesor of Complutense University, Madrid, Spain.
Board membership of Spanish Society of Hematology
Board membership of CAT (Spanish Society of Hematology)
Board membership of working group of Thrombotic Thrombocytopenic Purpura (TTP) Spanish group Coordinator of the Spanish TTP registry.
Board membership of GEA since 2020 (Spanish Apheresis group)
President of GEPTI (Immune Thrombocytopenic Purpura Spanish group since 2017-now
Board membership of the Spanish Thrombosis and Haemostasis Society (SETH)

More information soon.

Servicio de Oncología Médica, Hospital Universitario La Paz – IdiPAZ, Madrid.

Médico Adjunto del Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid (2007 – actualidad). Coordinador de la Unidad de Tumores Urológicos. Coordinador del Comité de Tumores Urológicos del Hospital Universitario La Paz.
Doctor en Medicina por la Universidad Autónoma de Madrid.

Profesor Asociado del Departamento de Medicina, Universidad Autónoma de Madrid.

Investigador del Instituto de Investigación del Hospital La Paz (IdiPAZ), dentro del grupo de Oncología Traslacional
Miembro de las siguientes sociedades científicas:

American Society of Clinical Oncology (ASCO)
European Society of Medical Oncology (ESMO)
Sociedad Española de Oncología Médica (SEOM)
GUARD Consortium (GenitoUrinary Alliance for Research and Development)
European Association of Urology (EAU)
Grupo Germinal

More information soon.

Próximamente

Sandra O. Rosillo Rodríguez, MD, PhD

Acute Cardiac Care Unit

ECMO and Shock Team Coordinator

Coordinator of Advanced Simulation Training Courses

Hospital Universitario la Paz, Madrid, Spain

National Representative Spain ESC ACVC

Próximamente

Currently Full Professor leading Pitie-Salpétrière APHP.Sorbonne Cardio-Oncology Program and Paris Est Clinical Investigation Center. Dr Salem is particularly interested in cardiovascular pharmacology, cardio-immunology, heart failure and drug-induced arrhythmias applied to cardio-oncology.

Dr. Antonia Sambola Ayala is a cardiologist accredited in acute cardiac care (ACC) by the European Society of Cardiology and holds a Doctor of Medicine from the Autonomous University of Barcelona. She completed a fellowship at Mount Sinai Hospital in New York under Dr. Valentín Fuster. Formerly an attending physician in ACC at Vall d'Hebron Hospital, she also founded, coordinated, and taught the Master in Translational Research at its Research Institute for a decade. She currently coordinates the Working Group on Cardiovascular Disease in Women of the Spanish Society of Cardiology and serves on the ESC Executive Committee. Dr. Sambola collaborates with the Government of Spain in the Cardiovascular Strategy under a gender perspective. She has authored over 150 publications and book chapters and maintains an active academic and research career.

More information soon.

Cardiologist specialized in cardiac imaging and cardio-oncology, currently at Hospital Universitario Quirónsalud Madrid. She previously worked in the imaging section at Hospital Universitario La Paz. Her expertise covers advanced echocardiography, cardiac CT, and CMR in cancer patients. She holds ESC certification in transthoracic echocardiography and IC-OS certification in cardio-oncology. She has contributed to international multicenter registries. Actively engaged in teaching, she is faculty in master’s programs and a speaker at scientific meetings. Her work focuses on clinical focus and multimodality imaging for early diagnosis and patient-centered care in ardio-oncology.

Prof. Carlo Gabriele Tocchetti is currently Associate Professor of Medicine in the Department of Translational Medical Sciences, Federico II University, Naples, Italy since 2014, where he is Director of the Internal Medicine Unit for cancer patients and has established himself as a HF basic and clinical investigator. Prof Tocchetti is President, International Cardio-Oncology Society (ICOS) Italy Chapter, Fellow of the HFA, Chair of the Basic Science Section of the HFA, and Board member of the ESC Council on Cardio-Oncology.

The main goal of his lab is to explore pathophysiologic mechanisms and therapeutic targets in cardiac dysfunction, with a particular interest on post-ischemic HF, genetic and inflammatory cardiomyopathies, Pulmonary Hypertension and RV dysfunction, and HF due to antineoplastic therapies, including novel anticancer immunotherapies and biologic drugs employed in inflammatory diseases.

Professor Peter van der Meer, MD, PhD

Peter van der Meer is a clinical cardiologist and chair of the Department of Experimental Cardiology at University Medical Center Groningen. He is also a Professor of Heart Failure and Translational Cardiology at the University of Groningen. Peter received both his MD and PhD cum laude from the University of Groningen, and completed a postdoctoral fellowship at Harvard Medical School to train his skills in stem cell biology. His research group consists of PhD students and post-docs with various backgrounds (biologists, medical doctors and biomedical-engineers) working on translational research topics to bridge the gap between the bench and bedside. Professor van der Meer’s research focusses on understanding the susceptibility to develop heart failure and on exploring novel treatment targets and therapies. In 2024 he was voted by his peers as president-elect of the Council of CardioOncology of the ESC and member of the taskforce of the ESC who wrote the first Guidelines on Cardio-Oncology. He has received funding from several agencies including the Dutch Heart Foundation, NWO, European Union H2020 program, the HFSP and has been awarded an ERC starting and ERC consolidator grant.

More information soon.

Licenciada en Medicina por la Universidad Complutense y Dra. en Medicina por la Universidad Autónoma de Madrid. Máster en Cuidados Paliativos y Tratamiento de Soporte del Paciente neoplásico.

Facultativo Especialista de Área de Oncología Médica en el Hospital Universitario La Paz de Madrid y Profesora Asociada de Medicina en el Departamento de Medicina de la Universidad Autónoma de Madrid.

Participa como investigadora principal en ensayos clínicos relacionados con la especialidad, con especial dedicación al cáncer de mama.

Publica artículos en revistas nacionales e internacionales, colabora como autora y/o editora en libros relacionados con la Oncología Médica.

Eduardo Zatarain Nicolás is a medical doctor (MD) specialised in clinical cardiology and a clinical researcher at Hospital General Universitario Gregorio Marañón in Madrid. Dr Zatarain obtained his PhD at Complutense University (Madrid, Spain) in the field of cardiomyopathies. His research has been related to heart failure and transplant, cardiomyopathies, and is currently participating in national and international cardio-oncology research projects.

Dr Zatarain is a founder and currently leading the cardio-onco-haematology (COH) program at Hospital General Universitario Gregorio Marañón.

He is a member of the Spanish Society of Cardiology and an integrant of the Executive Committee of its COH Working Group. He is also a member of the Cardio-oncology Council from ESC.
He is an ICOS member, he has obtained the Board Certificate Exam of ICOS and takes an active part in its Advocacy Committee. Eduardo is also coordinating the Spanish Webinars of ICOS in collaboration with ILACO Society (Sociedad Iberolatinoamericana de cardiooncología).

Faculty

Pilar Agudo Quílez

Alicia Aguirre Lora

Jorge Álvarez Troncoso

Pietro Ameri

Marianne Aznar

Jutta Bergler-Klein

Annamaria Brioli

Chiara Bucciarelli-Ducci

Virginia Calvo

Miguel Canales

Daniela Cardinale

Juan Caro Códon

Almudena Castro Conde

Sergio Cinza Sanjurjo

Cristina Contreras Lorenzo

Raúl Córdoba Mascuñano

Regina Dalmau

Javier de Castro Carpeño

Raquel de Paz Arias

Guillermo de Velasco de Rueda

Victoria Delgado

Santo Dellegrottaglie

José Luis Díaz Díaz

Rocío Eiros

Marta Fanlo Maresma

Dimitrios Farmakis

Cristina Feijoo Cano

José Javier Fuster

María Rosaria Galdiero

Valentín García

Inés García Lunar

Alessandra Ghigo

José Ángel Hernández Rivas

Oliver Higuera

Borja Ibáñez

Dolores Isla Casado

Diego Jiménez Bou

Juan Pedro Justel

Lorenz Lehmann

Estefanía Linares

Teresa López-Fernández

Rebeca Lorca

Alexander Lyon

Pilar Martín

Ana Martín

Vicente Martín Sánchez

Amparo Martínez Monzonis

Pilar Mazón

Dolores Mesa

Cristina Mitroi

Pedro Moliner

Vicente Pallarés

Cristina Pascual

Milagros Pedreira

Álvaro Pinto

Gabriela Rodríguez Macías

Isabel Rodríguez

Sandra Rosillo

Leticia Ruiz-Giménez

Joe-Eli Salem

Antonia Sambola

Irene Sánchez Vadillo

Belén Terol

Carlo Gabriele Tocchetti

Peter van der Meer

Natalia Vidal Cassinello

Lucrecia Yáñez

Pilar Zamora

Eduardo Zatarain